07.25.23
More than ten cell and gene therapies have been approved by the FDA in the past five years,1 and over 500 gene-based therapies are in clinical development2 as of 2023.
In our July 18, 2023, webinar titled “False Claims Act 2023: What Every Health Care Entity Working with the Government Needs to Know,” Manatt posed the following hypothetical and asked three questions about it in our live poll.
07.24.23
On July 13, the Centers for Medicare & Medicaid Services released its annual proposed rule updating the Medicare Physician Fee Schedule for calendar year 2024.
In the last monthly Update to Manatt’s Regulation Tracker, we predicted that the Commission would not slow down for summer. How right we were.
07.21.23
On July 20, 2023, the OCR at the HHS and the FTC sent a joint letter to approximately 130 hospital systems and telehealth providers to alert them to the “serious privacy and security risks” stemming from the use of online tracking technologies integrated into their websites and mobile ...
07.20.23
On July 12, 2023, the U.S. Senate Committee on the Judiciary’s Subcommittee on Intellectual Property held its second hearing on artificial intelligence (AI) and intellectual property (IP).
07.18.23
In Finjan LLC v. ESET, LLC, the Federal Circuit held that a definition provided in any incorporated-by-reference document is a part of the host patent.
After a COVID-19-related delay, on June 27, the Department of Health and Human Services Office of Inspector General released a long-awaited final rule that establishes monetary penalties for violations of health information technology information blocking rules.
In a highly anticipated ruling, the California Supreme Court has held that employees may still have standing to sue for Labor Code violations in a representative capacity, even when their individual claims have been compelled to arbitration.
07.17.23
The crypto industry secured a key victory in its court battles with the Securities and Exchange Commission (SEC or Commission) on Thursday, July 13, when Judge Analisa Torres of the U.S. District Court for the Southern District of New York said that Ripple did not break the law when the ...